Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-28

FDA Approved: PROAIR DIGIHALER — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

FDA approved a supplemental application for ProAir Digihaler (albuterol sulfate) from Teva Respiratory, LLC. The approval covers changes related to the Digihale…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ProAir Digihaler (albuterol sulfate)

Snippet

SUPPL AP for PROAIR DIGIHALER (ALBUTEROL SULFATE)